Concord Biotech Ltd. provides pharmaceutical products. The Company offers active pharmaceutical ingredients, finished dosages formulations, and other related products, as well as provides contract research and manufacturing services. Concord Biotech serves customers in India.
The IPO consists of offer for sale of 21M shares by Helix Investment Holdings at a price band of INR705ā741/share. Through this IPO, Concord seeks...